Podoplanin Antikörper (FITC)
Kurzübersicht für Podoplanin Antikörper (FITC) (ABIN2853606)
Target
Alle Podoplanin (PDPN) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- This antibody reacts with mouse Aggrus/Podoplanin.
-
Aufreinigung
- Protein G agarose
-
Immunogen
- NL-17 cell membrane fraction
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
Buffer
- PBS, 0.09 % NaN3, 1 % BSA
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8 °C.
-
-
- Podoplanin (PDPN)
-
Andere Bezeichnung
- Podoplanin
-
Hintergrund
- In addition to hemostasis and host defense, platelets are involved in the induction of inflammation, tissue repair, and tumor metastasis. Aggrus (T1α/Podoplanin) is a novel 36-45 kDa membrane sialoglycoprotein that induces platelet aggregation. Aggrus is highly expressed in various tumor cells and the platelet aggregation ability of Aggrus depends on specific oligosaccharide structures that may be related to the metastasis process in cancer cells. Aggrus has been identified as a diagnostic tumor marker for seminoma and testicular cancers.Synonyms: Aggrus, GP36, Glycoprotein 36, PA2.26 antigen, PDPN, PSEC0003, PSEC0025, T1-alpha
-
Gen-ID
- 10630
-
NCBI Accession
- NP_001006625
-
UniProt
- Q86YL7
-
Pathways
- Dicarboxylic Acid Transport
Target
-